Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 4.80% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 10.78% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -89.45% |
| Jun 30, 2025 | -89.89% |
| Mar 31, 2025 | 2.50% |
| Dec 31, 2024 | -3.10% |
| Sep 30, 2024 | -90.48% |
| Jun 30, 2024 | -91.99% |
| Mar 31, 2024 | -92.75% |
| Dec 31, 2023 | -30.12% |
| Sep 30, 2023 | -39.08% |
| Jun 30, 2023 | -37.36% |
| Mar 31, 2023 | -31.10% |
| Dec 31, 2022 | -25.73% |
| Sep 30, 2022 | -23.26% |
| Jun 30, 2022 | -18.72% |
| Mar 31, 2022 | -19.83% |
| Dec 31, 2021 | -2.74% |
| Sep 30, 2021 | 9.89% |
| Jun 30, 2021 | 11.35% |
| Mar 31, 2021 | 11.04% |
| Dec 31, 2020 | 17.03% |